Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ff283c7d6797987f01db547f606e6b32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_658df3b9d24eb5224b37aaf605741db6 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C49-84 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C49-755 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D311-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D495-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D217-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D313-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-06 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-74 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-35 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-353 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-18 |
filingDate |
2014-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f273dd6312285e7ef4c9e100a28b51cb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d4437835d6c256610586a62f2055b7fd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_27a73d2d9006704443bcd6c3a91b961a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e7d9f6e037a7170c2f887e23ba540238 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9b11ce3d2439eff5ae6830cc2c1a09a8 |
publicationDate |
2016-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-2994460-A1 |
titleOfInvention |
Compounds for treatment of angiogenesis-mediated diseases |
abstract |
Synthetic cremastranone and cremastranone analogs are disclosed. Additionally, methods for synthesizing cremastranone and cremastranone analogs are disclosed. Methods of treating ocular neovascularization disorders and treating angiogenesis-mediated disease are also disclosed. |
priorityDate |
2013-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |